<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319712445374</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319712445374</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Carotid Artery Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A High Prevalence of Carotid Artery Stenosis in Male Patients Older Than 65 Years, Irrespective of Presenting Clinical Manifestation of Atherosclerotic Diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kazemi-Bajestani</surname>
<given-names>Seyyed Mohammad Reza</given-names>
</name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff1-0003319712445374">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van der Vlugt</surname>
<given-names>Maureen</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-0003319712445374">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Leeuw</surname>
<given-names>Frank-Erik</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff3-0003319712445374">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blankensteijn</surname>
<given-names>Jan D.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-0003319712445374">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bredie</surname>
<given-names>Sebastian J. H.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319712445374">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319712445374"/>
</contrib>
</contrib-group>
<aff id="aff1-0003319712445374">
<label>1</label>Department of General Internal Medicine, Radboud University, Medical Centre Nijmegen, The Netherlands</aff>
<aff id="aff2-0003319712445374">
<label>2</label>Department of Cardiology, Radboud University, Medical Centre Nijmegen, The Netherlands</aff>
<aff id="aff3-0003319712445374">
<label>3</label>Department of Neurology, Radboud University, Medical Centre Nijmegen, The Netherlands</aff>
<aff id="aff4-0003319712445374">
<label>4</label>Department of Surgery, Vrije Universiteit Medical Center, Amsterdam, The Netherlands</aff>
<author-notes>
<corresp id="corresp1-0003319712445374">Sebastian J. H. Bredie, Department of General Internal Medicine, Radboud University, Medical Centre Nijmegen, Postbus 9101, 6500 HB Nijmegen, The Netherlands. Email: <email>s.bredie@aig.umcn.nl</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>64</volume>
<issue>4</issue>
<fpage>281</fpage>
<lpage>286</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>This study investigated the prevalence of carotid artery stenosis (CS) and the association with various risk factors in male patients (&gt;65 years) diagnosed with cardiovascular diseases. Duplex sonography of the carotid arteries was performed in 434 of 473 eligible patients of whom 118 (27.8%) patients had significant CS ≥50%. The prevalence and severity of CS did not differ between patients who presented with neurological symptoms or acute coronary syndrome/peripheral artery disease (30.8% vs 25.9%, respectively). Among patients with CS, a higher rate of current smoking, a higher systolic blood pressure, and a lower glomerular filtration rate were observed compared with patients without CS. A history of coronary artery bypass graft was a significant predictor of the presence of CS (<italic>P</italic> = .003, odds ratio [OR] = 2.70 [1.40-5.19]). The prevalence of CS in elderly males with manifest atherosclerotic disease is high, irrespective of presenting clinical manifestation.</p>
</abstract>
<kwd-group>
<kwd>carotid artery stenosis</kwd>
<kwd>atherosclerosis</kwd>
<kwd>elderly males</kwd>
<kwd>screening</kwd>
<kwd>prevalence</kwd>
<kwd>risk factors</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0003319712445374">
<title>Introduction</title>
<p>Atherosclerotic carotid artery stenosis (CS) is an important cause of morbidity and mortality.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712445374">1</xref>,<xref ref-type="bibr" rid="bibr2-0003319712445374">2</xref>
</sup> The annual stroke risk has been reported to be approximately 0.2% in the general population<sup>
<xref ref-type="bibr" rid="bibr3-0003319712445374">3</xref>
</sup> and 2% to 5% in patients with severe asymptomatic CS,<sup>
<xref ref-type="bibr" rid="bibr4-0003319712445374">4</xref>,<xref ref-type="bibr" rid="bibr5-0003319712445374">5</xref>
</sup> increasing to 5% in patients presenting with transient ischemic attack (TIA).<sup>
<xref ref-type="bibr" rid="bibr6-0003319712445374">6</xref>
</sup> Furthermore, mortality with internal CS (ICS)-related stroke may be as high as 45% during follow up of 1.2 years.<sup>
<xref ref-type="bibr" rid="bibr7-0003319712445374">7</xref>
</sup> However, a prevalence of only about 0% to 3.1% of severe asymptomatic CS has been observed in the general population.<sup>
<xref ref-type="bibr" rid="bibr8-0003319712445374">8</xref>
</sup>
</p>
<p>Carotid artery stenosis is a manifestation of atherosclerotic diseases and its coexistence with coronary artery diseases (CADs)<sup>
<xref ref-type="bibr" rid="bibr9-0003319712445374">9</xref>
</sup> and peripheral artery diseases (PADs)<sup>
<xref ref-type="bibr" rid="bibr10-0003319712445374">10</xref>
</sup> is considerable. In the patients with PAD, the prevalence of ICS is up to 28%.<sup>
<xref ref-type="bibr" rid="bibr10-0003319712445374">10</xref>
<xref ref-type="bibr" rid="bibr11-0003319712445374"/>
<xref ref-type="bibr" rid="bibr12-0003319712445374"/>
<xref ref-type="bibr" rid="bibr13-0003319712445374"/>–<xref ref-type="bibr" rid="bibr14-0003319712445374">14</xref>
</sup> The presence of carotid bruits is associated with higher rate of myocardial infarction (MI) morbidity and mortality.<sup>
<xref ref-type="bibr" rid="bibr15-0003319712445374">15</xref>
</sup> The European Society for Vascular Surgery recommended aggressive preventive approaches for the patients with CS.<sup>
<xref ref-type="bibr" rid="bibr16-0003319712445374">16</xref>
</sup>
</p>
<p>Significant CS (≥50%) was observed in 59% of patients who underwent preoperative carotid artery duplex scanning before coronary artery bypass graft (CABG) procedure.<sup>
<xref ref-type="bibr" rid="bibr17-0003319712445374">17</xref>
</sup> Furthermore, increased carotid plaque thickness is associated with an increased risk of combined vascular events compared with the participants without carotid plaque.<sup>
<xref ref-type="bibr" rid="bibr9-0003319712445374">9</xref>
</sup> Either symptomatic or asymptomatic CS is associated with atherosclerotic vascular wall abnormalities,<sup>
<xref ref-type="bibr" rid="bibr18-0003319712445374">18</xref>,<xref ref-type="bibr" rid="bibr19-0003319712445374">19</xref>
</sup> male gender,<sup>
<xref ref-type="bibr" rid="bibr20-0003319712445374">20</xref>,<xref ref-type="bibr" rid="bibr21-0003319712445374">21</xref>
</sup> and established predisposing risk factors for atherosclerosis.<sup>
<xref ref-type="bibr" rid="bibr20-0003319712445374">20</xref>
<xref ref-type="bibr" rid="bibr21-0003319712445374"/>–<xref ref-type="bibr" rid="bibr22-0003319712445374">22</xref>
</sup> Furthermore, the prevalence of CS is associated with hypercholesterolemia,<sup>
<xref ref-type="bibr" rid="bibr23-0003319712445374">23</xref>
</sup> diabetes mellitus,<sup>
<xref ref-type="bibr" rid="bibr24-0003319712445374">24</xref>
</sup> high systolic blood pressure,<sup>
<xref ref-type="bibr" rid="bibr25-0003319712445374">25</xref>
</sup> and tobacco smoking.<sup>
<xref ref-type="bibr" rid="bibr26-0003319712445374">26</xref>
</sup> Also, glomerular filtration rate (GFR), most likely as a marker of glomerular atherosclerosis, was found as an independent predictor of carotid atherosclerosis in patients with CAD.<sup>
<xref ref-type="bibr" rid="bibr27-0003319712445374">27</xref>
</sup>
</p>
<p>Because of high sensitivity and specificity, noninvasive screening of CS by ultrasonography is applicable to investigate the presence and severity of atherosclerotic disease.<sup>
<xref ref-type="bibr" rid="bibr28-0003319712445374">28</xref>
</sup> Duplex ultrasonography which is performed without additional imaging is cost effective in the selection of symptomatic patients suitable for endarterectomy.<sup>
<xref ref-type="bibr" rid="bibr29-0003319712445374">29</xref>
</sup> Screening for treatable causes of potential stroke can be cost effective, depending on the population at risk. The prevalence of severe CS increases with age and gender.<sup>
<xref ref-type="bibr" rid="bibr20-0003319712445374">20</xref>
</sup> Therefore, screening for causes of stroke, which may have consequences for treatment, seems most effective in male patients in the age above 65 years with manifest atherosclerotic disease.<sup>
<xref ref-type="bibr" rid="bibr30-0003319712445374">30</xref>
</sup>
</p>
<p>In the current study, we evaluated the prevalence and severity of CS in elderly male patients referred for TIA/ischemic stroke, acute coronary syndrome (ACS), or PAD, in order to determine the efficacy of screening in these specific groups. Furthermore, we evaluated the predictive value of predisposing risk factors in either symptomatic (referred for TIA or ischemic stroke) or asymptomatic patients (no TIA or stroke) in this population.</p>
</sec>
<sec id="section2-0003319712445374" sec-type="methods">
<title>Methods</title>
<p>For this study, we used an existing registry of patients with an atherosclerotic cardiovascular event (TIA/ischemic stroke, ACS, or PAD) who were referred to our hospital between 2007 and 2009. The database consists of a complete cardiovascular risk profile of 2591 patients with manifest atherosclerotic (n = 1976) disease or elevated cardiovascular risk (n = 615), including relevant biochemical analysis (fasting lipid profile, fasting glucose levels, and GFR calculated by the Cockroft-Gault equation<sup>
<xref ref-type="bibr" rid="bibr31-0003319712445374">31</xref>
</sup>), anthropometry, and complete cardiovascular medical history. Duplex ultrasound evaluation of the carotid arteries was routinely advised in all male patients above the age of 65 years (n = 473; 23.9% of 1976). Because of loss in follow-up (patient returned to previous doctor in other hospital or general practitioner) and for logistic reasons CS evaluation was carried out in 434 (91.8%) of 473 patients. Of these 434 patients, 117 patients were referred with manifest TIA or stroke.</p>
<p>Duplex screening of the carotid artery was performed using routine procedures. According to the results, individuals were categorized into CS(+) in case of a sonography-defined stenosis ≥50% (50%-70% stenosis: peak systolic velocities [PSVs] ratio 2-4 and/or PSVs &lt;210 cm/s, and end-diastolic velocity [EDV] &lt;100 cm/s; and 70%-99% stenosis: PSVs ratio ≥4 and/or PSVs &gt;210 cm/s, and EDV &gt;100 cm/s) in 1 of the major branches of left or right ICA or external carotid artery (ECA) or common carotid artery (CCA), and CS(−) in case of normal carotid arteries with stenosis &lt;50% (PSVs ratio &lt;2 and/or PSVs &lt;125 cm/s). All patients who had ischemic stroke or TIA in the recent 6 months before referral were considered to be “symptomatic.” All other male patients were considered to be “asymptomatic.” None of the patients developed TIA/stroke after initial referral.</p>
<sec id="section3-0003319712445374">
<title>Statistical Analysis</title>
<p>The data were evaluated using SPSS 16, with descriptive statistics (mean, median, standard deviation [SD], and interquartile range) determined for all variables. Normally distributed values were evaluated by <italic>t</italic> test and chi-square test, whereas nonparametric tests were used in the case of skewed distribution. Logistic regression analysis was used to predict the presence of CS on the basis of relevant risk factors. A <italic>P</italic> &lt; .05 (2-tailed) was considered significant.</p>
</sec>
</sec>
<sec id="section4-0003319712445374">
<title>Results</title>
<p>The mean age of the 434 evaluated participants was 68.3 ± 6.9 years. In all, 118 (27.8%) were CS(+) and 316 (72.8%) participants were CS(−). There was no significant difference in mean age, body mass index, or waist circumference between the 2 groups (<xref ref-type="table" rid="table1-0003319712445374">Table 1</xref>). Patients with CS(+) were more frequently smokers (36.4% vs 24.7%, <italic>P</italic> = .01) and presented with higher systolic blood pressure compared with CS(−) (149.7 ± 21.8 vs 144.1 ± 21.8, <italic>P</italic> = .02; <xref ref-type="table" rid="table1-0003319712445374">Table 1</xref>). Alcohol intake (&gt;5 u/week), diastolic blood pressure, lipid profile, and serum creatinine levels did not show significant differences between the 2 groups. However, calculated GFR was lower in patients with CS(+) compared with CS(−) (91 [82-108] vs 88 [77-105] mL/min, <italic>P</italic> = .005; <xref ref-type="table" rid="table1-0003319712445374">Table 1</xref>).</p>
<table-wrap id="table1-0003319712445374" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical and Biochemical Characteristics of the Patients With or Without Carotid Artery Stenosis (CS).<sup><xref ref-type="table-fn" rid="table-fn2-0003319712445374">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table1-0003319712445374" xlink:href="10.1177_0003319712445374-table1.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Total, n = 434</th>
<th>CS(+), n = 118 (27.2%)</th>
<th>CS(−), n = 316 (72.8%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (years)</td>
<td>69.5 ± 4.9</td>
<td>68.8 ± 3.7</td>
<td>69.7 ± 4.8</td>
</tr>
<tr>
<td>Current smoking</td>
<td>121 (27.9)</td>
<td>43 (36.4)</td>
<td>78 (24.7)<sup><xref ref-type="table-fn" rid="table-fn3-0003319712445374">b</xref></sup>
</td>
</tr>
<tr>
<td>Alcohol (&gt;5 u/week)</td>
<td>75 (17.3%)</td>
<td>22 (18.6%)</td>
<td>53 (16.8%)</td>
</tr>
<tr>
<td>BMI (kg/m<sup>2</sup>)</td>
<td>26.1 (24.1-29.1)</td>
<td>26.5 (24.6-29.5)</td>
<td>25.8 (23.60-28.9)</td>
</tr>
<tr>
<td>Waist circumference (cm)</td>
<td>98.5 ± 11.1</td>
<td>99.3 ± 11.4</td>
<td>98.2 ± 11.0</td>
</tr>
<tr>
<td>Systolic BP (mm Hg)</td>
<td>145.6 ± 21.9</td>
<td>149.7 ± 21.8</td>
<td>144.1 ± 21.8<sup><xref ref-type="table-fn" rid="table-fn4-0003319712445374">c</xref></sup>
</td>
</tr>
<tr>
<td>Diastolic BP (mm Hg)</td>
<td>77.8 ± 10.7</td>
<td>76.3 ± 10.2</td>
<td>78.4 ± 10.9</td>
</tr>
<tr>
<td>Cholesterol total (mmol/L)</td>
<td>4.2 (3.6-4.9)</td>
<td>4.2 (3.4-4.8)</td>
<td>4.1 (3.4-4.7)</td>
</tr>
<tr>
<td>HDL-C (mmol/L)</td>
<td>2.1 ± 1.1</td>
<td>1.1 ± 0.2</td>
<td>1.1 ± 0.02</td>
</tr>
<tr>
<td>LDL-C (mmol/L)</td>
<td>2.5 ± 0.8</td>
<td>2.4 ± 0.8</td>
<td>2.5 ± 0.7</td>
</tr>
<tr>
<td>Triglyceride (mmol/L)</td>
<td>1.4 (1.0-2.0)</td>
<td>1.4 (1.1-2.1)</td>
<td>1.4 (1.0-2.1)</td>
</tr>
<tr>
<td>GFR (mL/min)</td>
<td>79.6 ± 22.7</td>
<td>74.5 ± 21.7</td>
<td>81.4 ± 22.8<sup><xref ref-type="table-fn" rid="table-fn3-0003319712445374">b</xref></sup>
</td>
</tr>
<tr>
<td>Creatinine (μmol/L)</td>
<td>88 (79-102)</td>
<td>91 (82-108)</td>
<td>88 (77-105)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319712445374">
<p>Abbreviations: CS(+) and CS(−), patients with and without documented carotid artery stenosis (CS, on duplex sonography); BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein–cholesterol; LDL-C, low-density lipoprotein–cholesterol; GFR, glomerular filtration rate.</p>
</fn>
<fn id="table-fn2-0003319712445374">
<p>
<sup>a</sup> Values expressed as mean ± SD for normally distributed data, and median and interquartile range for nonnormally distributed data; the GFR was calculated using the Cockroft-Gault equation.</p>
</fn>
<fn id="table-fn3-0003319712445374">
<p>
<sup>b</sup> <italic>P</italic> &lt; .01, CS(+) versus CS(−).</p>
</fn>
<fn id="table-fn4-0003319712445374">
<p>
<sup>c</sup> <italic>P</italic> &lt; .05, CS(+) versus CS(−).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Patients with CS(+) had a more frequent medical history of CABG than those with CS(−) (17.8% vs 7.6%, <italic>P</italic> = .001). However, history of other cardiovascular diseases did not differ significantly between the 2 groups.</p>
<p>Of the 118 patients with CS, 99 (83.9%) had ICS. The number of ECA and CCA stenoses was 15 (12.7%) and 4 (3.4%), respectively (<xref ref-type="table" rid="table2-0003319712445374">Table 2</xref>). Regarding to the severity of stenosis, we found that 44 (37.3%) patients with CS had 70% to 99% stenosis in the ICA. Six (5.08%) and 1 (0.08%) of CS patients showed 70% to 99% stenosis in ECA and CCA, respectively (<xref ref-type="table" rid="table2-0003319712445374">Table 2</xref>).</p>
<table-wrap id="table2-0003319712445374" position="float">
<label>Table 2.</label>
<caption>
<p>The Involvement and Degree of Stenosis of Different Branches of the Carotid Artery.</p>
</caption>
<graphic alternate-form-of="table2-0003319712445374" xlink:href="10.1177_0003319712445374-table2.tif"/>
<table>
<thead>
<tr>
<th colspan="2" rowspan="2">
</th>
<th colspan="4">Rate of Stenosis</th>
</tr>
<tr>
<th>50%</th>
<th>50%-70%</th>
<th>70%-99%</th>
<th>100%</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3">The carotid branch with the highest degree of stenosis (n = 118)</td>
<td>ICA, n = 99 (83.9%)</td>
<td>11 (9.3%)</td>
<td>38 (32.2%)</td>
<td>44 (37.3%)</td>
<td>6 (5.0%)</td>
</tr>
<tr>
<td>ECA, n = 15 (12.7%)</td>
<td>3 (2.5%)</td>
<td>6 (5.08%)</td>
<td>6 (5.08%)</td>
<td>0 (0%)</td>
</tr>
<tr>
<td>CCA, n = 4 (3.4%)</td>
<td>1 (0.08%)</td>
<td>0 (0%)</td>
<td>1 (0.08%)</td>
<td>2 (1.6%)</td>
</tr>
<tr>
<td colspan="2">Total</td>
<td>15 (12.7%)</td>
<td>44 (37.2%)</td>
<td>51 (43.2%) </td>
<td>8 (6.8%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0003319712445374">
<p>Abbreviations: ICA, internal carotid artery; ECA, external carotid artery; CCA, common carotid artery.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Multiple logistic regression analysis was performed to assess the relative contribution of selected parameters (age, GFR, creatinine, systolic blood pressure, history of CABG, and smoking) to the presence of sonography-defined CS (<xref ref-type="table" rid="table3-0003319712445374">Table 3</xref>). History of CABG proved to be an independent significant predictor of CS (<italic>P</italic> = .003, OR = 2.70 [1.40-5.19]; <xref ref-type="table" rid="table3-0003319712445374">Table 3</xref>).</p>
<table-wrap id="table3-0003319712445374" position="float">
<label>Table 3.</label>
<caption>
<p>Assessment of the Relative Contribution of Selected Parameters to the Presence of Carotid Artery Stenosis (CS).<sup><xref ref-type="table-fn" rid="table-fn7-0003319712445374">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table3-0003319712445374" xlink:href="10.1177_0003319712445374-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Odds Ratio</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age</td>
<td>0.91 (0.94-1.03)</td>
<td>.70</td>
</tr>
<tr>
<td>GFR</td>
<td>1.01 (0.99-1.02)</td>
<td>.20</td>
</tr>
<tr>
<td>Creatinine</td>
<td>1.00 (0.98-1.01)</td>
<td>.86</td>
</tr>
<tr>
<td>Systolic blood pressure</td>
<td>0.99 (0.98-1.00)</td>
<td>.16</td>
</tr>
<tr>
<td>History of CABG</td>
<td>2.70 (1.40-5.19)</td>
<td>.003</td>
</tr>
<tr>
<td>Current smoking</td>
<td>1.58 (0.95-2.62)</td>
<td>.07</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0003319712445374">
<p>Abbreviations: CABG, coronary artery bypass graft; CS, carotid artery stenosis; GFR, glomerular filtration rate.</p>
</fn>
<fn id="table-fn7-0003319712445374">
<p>
<sup>a</sup> Adjusted odds ratios with 95% confidence intervals (95% CIs) obtained from multiple logistic regression. A <italic>P</italic> &lt; .05 was considered significant. The GFR was calculated using the Cockroft-Gault equation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The CS(+) patients with a 50% to 70% stenosis in 1 of the branches of the carotid artery were significantly older than patients in CS(−) group (70.8 ± 7.1 vs 67.8 ± 7, <italic>P</italic> = .027; <xref ref-type="table" rid="table4-0003319712445374">Table 4</xref>). Glomerular filtration rate levels in patients with 50% to 70% stenosis in 1 of the branches of carotid artery were significantly lower than the patients in CS(−) group (68.9 ± 18.5 vs 82.3 ± 22.9, <italic>P</italic> = .001; <xref ref-type="table" rid="table4-0003319712445374">Table 4</xref>). Creatinine levels of patients with occlusion of carotid artery was significantly higher than the group with 70% to 99% stenosis (120.8 ± 31.9 vs 90.1 ± 21.7 μmol/L, <italic>P</italic> = .008; <xref ref-type="table" rid="table4-0003319712445374">Table 4</xref>).</p>
<table-wrap id="table4-0003319712445374" position="float">
<label>Table 4.</label>
<caption>
<p>Risk Factors in Different Groups of the Patients With and Without Carotid Artery Stenosis (CS) by Different Degrees of CS.</p>
</caption>
<graphic alternate-form-of="table4-0003319712445374" xlink:href="10.1177_0003319712445374-table4.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>CS(−)</th>
<th colspan="4">CS(+)</th>
</tr>
<tr>
<th>
</th>
<th>CS &lt; 50%, n = 316</th>
<th>CS 50%, n = 15 (12.7%)</th>
<th>CS 50%-70%, n = 44 (37.2%)</th>
<th>CS 70%-99%, n = 51 (43.2%)</th>
<th>Occlusion, n = 8 (6.8%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (years)</td>
<td>67.8 ± 7</td>
<td>71.2 ± 6.6</td>
<td>70.8 ± 7.1<sup><xref ref-type="table-fn" rid="table-fn9-0003319712445374">a</xref></sup>
</td>
<td>67.4 ± 6.5</td>
<td>69.7 ± 4.4</td>
</tr>
<tr>
<td>BMI (kg/m<sup>2</sup>)</td>
<td>26.8 ± 4.7</td>
<td>26.3 ± 3.1</td>
<td>26.9 ± 3.3</td>
<td>26.7 ± 4.2</td>
<td>27.3 ± 4.4</td>
</tr>
<tr>
<td>Waist (cm)</td>
<td>98.5 ± 10.9</td>
<td>97.7 ± 11.7</td>
<td>99.4 ± 11.7</td>
<td>97.3 ± 11.3</td>
<td>105.5 ± 12.8</td>
</tr>
<tr>
<td>Systolic blood pressure (mm Hg)</td>
<td>143.8 ± 22.1</td>
<td>144.9 ± 21.3</td>
<td>149.4 ± 20.6</td>
<td>151.8 ± 19.7</td>
<td>160.4 ± 28.2</td>
</tr>
<tr>
<td>Diastolic blood pressure (mm Hg)</td>
<td>78.0 ± 10.8</td>
<td>71.6 ± 12.2</td>
<td>79.0 ± 11.2</td>
<td>79.2 ± 8.8</td>
<td>72.0 ± 1.4</td>
</tr>
<tr>
<td>Total cholesterol (mmol/L)</td>
<td>4.4 ± 0.9</td>
<td>4.2 ± 0.6</td>
<td>4.0 ± 0.6</td>
<td>4.4 ± 1.0</td>
<td>4.5 ± 1.8</td>
</tr>
<tr>
<td>Triglycerides (mmol/L)</td>
<td>1.6 ± 9.3</td>
<td>1.5 ± 0.6</td>
<td>1.4 ± 0.6</td>
<td>1.7 ± 0.9</td>
<td>1.1 ± 0.4</td>
</tr>
<tr>
<td>HDL-cholesterol (mmol/L)</td>
<td>1.1 ± 0.3</td>
<td>1.2 ± 0.3</td>
<td>1.1 ± 0.2</td>
<td>1.1 ± 0.2</td>
<td>1.2 ± 0.2</td>
</tr>
<tr>
<td>LDL-cholesterol (mmol/L)</td>
<td>2.5 ± 0.7</td>
<td>2.4 ± 0.6</td>
<td>2.2 ± 0.5</td>
<td>2.5 ± 0.9</td>
<td>2.5 ± 1.6</td>
</tr>
<tr>
<td>Creatinine (μmol/L)</td>
<td>92.3 ± 22.6</td>
<td>95.0 ± 23.2</td>
<td>99.0 ± 20.8</td>
<td>90.1 ± 21.7</td>
<td>120.8 ± 31.9<sup><xref ref-type="table-fn" rid="table-fn10-0003319712445374">b</xref></sup>
</td>
</tr>
<tr>
<td>Glomerular filtration rate (mL/min)<sup><xref ref-type="table-fn" rid="table-fn9-0003319712445374">a</xref></sup>
</td>
<td>82.3 ± 22.9</td>
<td>73.4 ± 22.2</td>
<td>68.9 ± 18.5<sup><xref ref-type="table-fn" rid="table-fn11-0003319712445374">c</xref></sup>
</td>
<td>79.8 ± 21.1</td>
<td>60.5 ± 17.8</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-0003319712445374">
<p>Abbreviations: CS, carotid artery stenosis; BMI, body mass index; HDL-C, high-density lipoprotein–cholesterol; LDL-C, low-density lipoprotein–cholesterol; glomerular filtration rate, calculated using the Cockroft-Gault equation.</p>
</fn>
<fn id="table-fn9-0003319712445374">
<p>
<sup>a</sup> Age of the patients with 50% to 70% of carotid stenosis was significantly higher than the patients in CS(−) group (post hoc test, <italic>P</italic> = .02).</p>
</fn>
<fn id="table-fn10-0003319712445374">
<p>
<sup>b</sup> Creatinine level of the patients with occlusion (100% CS; n = 8) was significantly higher than the group with 70% to 99% of stenosis (post hoc test, <italic>P</italic> = .008).</p>
</fn>
<fn id="table-fn11-0003319712445374">
<p>
<sup>c</sup> GFR of the patients with 50% to 70% CS was significantly lower than the patients in CS(−) group (post hoc test, <italic>P</italic> = .001).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In our population, 36 (30.5%) of 118 patients with CS were symptomatic (presented with TIA or stroke). However, 81 (25.6%) patients without CS also presented with TIA or stroke. There was no significant association between the presence of CS and CS-related symptoms (TIA or stroke) in this population (<xref ref-type="table" rid="table5-0003319712445374">Table 5</xref>). Comparisons between traditional risk factors for CS patients with and without presenting neurological symptoms did not show any significant difference (<italic>P</italic> &gt; .05; <xref ref-type="table" rid="table6-0003319712445374">Table 6</xref>).</p>
<table-wrap id="table5-0003319712445374" position="float">
<label>Table 5.</label>
<caption>
<p>Percentage of Symptomatic Patients With and Without Carotid Artery Stenosis (CS).<sup><xref ref-type="table-fn" rid="table-fn12-0003319712445374">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table5-0003319712445374" xlink:href="10.1177_0003319712445374-table5.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>CS(+), n = 118</th>
<th>CS(–), n = 316</th>
</tr>
</thead>
<tbody>
<tr>
<td>Symptomatic (TIA/stroke), n = 117</td>
<td>36 (30.8% of all symptomatic patients)</td>
<td>81 (69.2% of all symptomatic patients)</td>
</tr>
<tr>
<td>Asymptomatic, n = 317</td>
<td>82 (25.9% of all asymptomatic patients)</td>
<td>235 (74.1% of all asymptomatic patients)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn12-0003319712445374">
<p>
<sup>a</sup> There was no significant difference between the prevalence of CS in symptomatic or asymptomatic patients (chi-square test; <italic>P</italic> &gt; .05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table6-0003319712445374" position="float">
<label>Table 6.</label>
<caption>
<p>Clinical and Biochemical Characteristics of the Symptomatic and Asymptomatic Patients With Carotid Artery Stenosis (CS; n = 118).<sup><xref ref-type="table-fn" rid="table-fn14-0003319712445374">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table6-0003319712445374" xlink:href="10.1177_0003319712445374-table6.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Symptomatic, n = 36 (30.5%)</th>
<th>Asymptomatic, n = 82 (69.5%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (years)</td>
<td>69.3 ± 3.4</td>
<td>68.6 ± 4.2</td>
</tr>
<tr>
<td>Current smoking</td>
<td>14 (38.8)</td>
<td>29 (35.4)</td>
</tr>
<tr>
<td>Alcohol (&gt;5 u/week)</td>
<td>6 (16.7)</td>
<td>16 (19.5)</td>
</tr>
<tr>
<td>BMI (kg/m<sup>2</sup>)</td>
<td>27.0 ± 4.2</td>
<td>26.6 ± 3.6</td>
</tr>
<tr>
<td>Waist circumference (cm)</td>
<td>98.2 ± 13.5</td>
<td>97.2 ± 9.2</td>
</tr>
<tr>
<td>Systolic BP (mm Hg)</td>
<td>149.7 ± 21.8</td>
<td>142.4 ± 18.4</td>
</tr>
<tr>
<td>Diastolic BP (mm Hg)</td>
<td>76.3 ± 10.2</td>
<td>78.0 ± 10.4</td>
</tr>
<tr>
<td>Total cholesterol (mmol/L)</td>
<td>4.2 ± 0.6</td>
<td>4.2 ± 0.9</td>
</tr>
<tr>
<td>HDL-C (mmol/L)</td>
<td>1.1 ± 0.2</td>
<td>1.1 ± 0.7</td>
</tr>
<tr>
<td>LDL-C (mmol/L)</td>
<td>2.4 ± 0.8</td>
<td>2.5 ± 0.7</td>
</tr>
<tr>
<td>Triglyceride (mmol/L)</td>
<td>1.3 (1.0-2.4)</td>
<td>1.5 (1.0-2.0)</td>
</tr>
<tr>
<td>GFR (mL/min)</td>
<td>72.4 ± 20.6</td>
<td>75.4 ± 19.8</td>
</tr>
<tr>
<td>Creatinine (μmol/L)</td>
<td>87 (84-104)</td>
<td>84 (76-102)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn13-0003319712445374">
<p>Abbreviations: CS(+) and CS(−), patients with and without documented CS (based on duplex sonography); BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein–cholesterol; LDL-C, low-density lipoprotein–cholesterol; GFR, glomerular filtration rate, calculated using the Cockroft-Gault equation.</p>
</fn>
<fn id="table-fn14-0003319712445374">
<p>
<sup>a</sup> Values expressed as mean ± SD for normally distributed data, and median and interquartile range for nonnormally distributed data. There were no significant differences between symptomatic and asymptomatic patients (<italic>P</italic> &gt; .05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section5-0003319712445374">
<title>Discussion</title>
<p>In our study, 27.2% of male patients above the age of 65 with prior manifestation of atherosclerosis appeared to have CS (≥50%). This high percentage of the patients with CS in our study is directly related to the fact that 37% of the case mix was referred for TIA or stroke, in which CS is highly prevalent.<sup>
<xref ref-type="bibr" rid="bibr32-0003319712445374">32</xref>,<xref ref-type="bibr" rid="bibr33-0003319712445374">33</xref>
</sup> However, 82 (25.8%) of the 317 patients without TIA or stroke appeared to have CS &gt;50%, of which 59 (13.6%) presented with severe CS (degree of stenosis &gt;70%). Therefore, the difference in prevalence of CS ≥50% between patients with TIA/stroke and the patients with other manifestations of atherosclerotic disease (MI or PAD) seems clinically comparable (30.8% vs 25.8%, respectively).</p>
<p>Our findings are consistent with the results of a recent meta-analysis in patients with PAD, in which a prevalence of 28% asymptomatic CS (≥50%) was reported.<sup>
<xref ref-type="bibr" rid="bibr34-0003319712445374">34</xref>
</sup> Yun et al also reported that the prevalence of ICS (≥70%) was 14% in patients with atherosclerotic lower extremity ischemia.<sup>
<xref ref-type="bibr" rid="bibr35-0003319712445374">35</xref>
</sup>
</p>
<p>Several previous investigations showed that serum total cholesterol,<sup>
<xref ref-type="bibr" rid="bibr23-0003319712445374">23</xref>
</sup> low-density lipoprotein–cholesterol,<sup>
<xref ref-type="bibr" rid="bibr36-0003319712445374">36</xref>
</sup> and high-density lipoprotein–cholesterol<sup>
<xref ref-type="bibr" rid="bibr25-0003319712445374">25</xref>
</sup> are independent predictors of CS. However, the protective effect depends on various aspects, such as lipid levels and duration of lipid-lowering therapy and other risk factors. In our study population, the use of lipid-lowering medication prior to the event was widespread or initiated directly after the event. Therefore, significant difference between the serum levels of components of lipid profile could not been detected in our study, because of an equal use of lipid-lowering drugs in both groups.</p>
<p>The systolic blood pressure was associated with the presence of CS in the male patients with manifest atherosclerotic diseases. Although blood pressure was treated in all patients in our study, the systolic blood pressure of the patients with CS remained significantly higher than the patients without CS. This finding that systolic blood pressure was independently associated with CS was reported by Mathiesen et al in a large cohort of patients screened for CS with duplex ultrasound.<sup>
<xref ref-type="bibr" rid="bibr25-0003319712445374">25</xref>
</sup>
</p>
<p>We found a significant association between decreased GFR and presence of CS in male patients with manifest atherosclerotic diseases. Furthermore, GFR of the patients with 50% to 70% CS was lower than CS(−) patients. Glomerular filtration rate is an independent predictor of carotid atherosclerosis development in the patients with CAD.<sup>
<xref ref-type="bibr" rid="bibr27-0003319712445374">27</xref>
</sup> However, the finding of a reduced GFR in the male CS patients has not being reported previously. The European Society of Cardiology guideline suggested an association between decreased GFR and increased peripheral arterial risk.<sup>
<xref ref-type="bibr" rid="bibr37-0003319712445374">37</xref>
</sup> Lisowska et al demonstrated that decreased GFR is associated with preclinical stages of atherosclerotic changes, including carotid atherosclerosis.<sup>
<xref ref-type="bibr" rid="bibr38-0003319712445374">38</xref>
</sup> Probably, systemic atherosclerotic disease in patients presenting with CS also influences glomerular function by concomitant atherosclerosis of the renal arteries. Moreover, diminished glomerular filtration function is generally related to increased systolic blood pressure, as observed in this population. Although linearity between CS severity and diminished GFR occurred, the predictive value of GFR for CS on an individual basis is limited. According to the beneficial effects of statins on GFR,<sup>
<xref ref-type="bibr" rid="bibr39-0003319712445374">39</xref>
</sup> it can be recommended for CS which may prevent the development of CS with a systemic vascular effect. In our study most of the patients were on statin therapy after the major vascular events, therefore we are not able to assess the effects of statins on GFR levels. Further studies need to be done in this regard.</p>
<p>Our results did not confirm a marked relation between alcohol consumption and CS presence that is consistent with the findings of Zureik et al.<sup>
<xref ref-type="bibr" rid="bibr40-0003319712445374">40</xref>
</sup> Mowbray et al also reported the association between intima–media thickness and alcohol consumption, only in women but not in men.<sup>
<xref ref-type="bibr" rid="bibr41-0003319712445374">41</xref>
</sup> Although Hajat et al observed an association between alcohol consumption and TIA or stroke occurrence in a case–control study,<sup>
<xref ref-type="bibr" rid="bibr42-0003319712445374">42</xref>
</sup> we were not able to observe this in these male patients with atherosclerosis.</p>
<p>Our results about the relationship between smoking and prevalence of CS are in accordance with the findings that demonstrated a higher percentage of smoking history in the patients with prior features of atherosclerosis and CS than the patients of the same population without CS.<sup>
<xref ref-type="bibr" rid="bibr26-0003319712445374">26</xref>
</sup>
</p>
<p>According to our results, there were no significant difference between the existence of overt cardiovascular events (MI, cerebral bleeding, ischemia, TIA, and intermittent claudication) and presence of CS in the sample population with the history of manifest atherosclerosis. However, a significant predictive relation between previous CABG and prevalence of CS was observed.</p>
<p>Birincioğlu et al investigated 678 consecutive patients who underwent preoperative carotid artery duplex scanning before CABG procedure and found significant CS (≥50%) in 59% of the patients.<sup>
<xref ref-type="bibr" rid="bibr17-0003319712445374">17</xref>
</sup> Therefore, the prelikelihood of CS, which may be severe, in CABG patients supports screening in this subset of patients. Remarkably, the presence of ischemic stroke or TIA did not differ significantly between our patients with or without CS. This finding indicates that CS screening for severe CS should not be restricted to symptomatic patients but may reveal equal amounts of severe CS in male patients presenting with MI and PAD.</p>
<p>So far, we could not detect predictive risk factors for symptomatic disease in the presence of CS, which however is in line with Dharmasaroja et al who did not find any significant difference between cardiovascular risk factors for symptomatic patients with or without CS.<sup>
<xref ref-type="bibr" rid="bibr26-0003319712445374">26</xref>
</sup>
</p>
<p>Rigorous evaluation of male patients older than 65 years with manifest atherosclerotic disease reveals a high portion of significant CS, irrespective of presenting vascular symptoms. Systolic blood pressure, smoking, and decreased GFR level seem to be associated with the presence of CS in the patients with atherosclerotic disease, whereas a history of CABG may be independently predictive in atherosclerotic male patients. In more than 40% of the cases, this may have management consequences due to the severity of the stenosis. Based on this study, screening strategy cannot be refined by individual cardiovascular risk factors or symptoms of atherosclerotic disease other than previous CABG.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-0003319712445374">
<label>Authors’ Note</label>
<p>This work has not been presented in any congress.</p>
</fn>
<fn fn-type="conflict" id="fn2-0003319712445374">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0003319712445374">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: SMR K-B was a MD, MSc student of Biomedical Sciences funded by a scholarship of the “Stichting Studiefonds UMC St Radboud”, Nijmegen, The Netherlands.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319712445374">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shields</surname>
<given-names>RC</given-names>
</name>
</person-group>. <article-title>Medical management of carotid stenosis</article-title>. <source>Perspect Vasc Surg Endovasc Ther</source>. <year>2010</year>;<volume>22</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr2-0003319712445374">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbott</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Bladin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Levi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>BR</given-names>
</name>
</person-group>. <article-title>What should we do about asymptomatic carotid stenosis?</article-title> <source>Int J Stroke</source>. <year>2007</year>;<volume>2</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr3-0003319712445374">
<label>3</label>
<citation citation-type="journal">
<collab collab-type="author">European Registers of Stroke (EROS) Investigators</collab>, <person-group person-group-type="author">
<name>
<surname>Heuschmann</surname>
<given-names>PU</given-names>
</name>
<name>
<surname>Di Carlo</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Incidence of stroke in Europe at the beginning of the 21st century</article-title>. <source>Stroke</source>. <year>2009</year>;<volume>40</volume>(<issue>5</issue>):<fpage>1557</fpage>–<lpage>1563</lpage>.</citation>
</ref>
<ref id="bibr4-0003319712445374">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norris</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>CZ</given-names>
</name>
<name>
<surname>Bornstein</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>BR</given-names>
</name>
</person-group>. <article-title>Vascular risks of asymptomatic carotid stenosis</article-title>. <source>Stroke</source>. <year>1991</year>;<volume>22</volume>(<issue>12</issue>):<fpage>1485</fpage>–<lpage>1490</lpage>.</citation>
</ref>
<ref id="bibr5-0003319712445374">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inzitari</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Eliasziw</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gates</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators</article-title>. <source>N Engl J Med</source>. <year>2000</year>;<volume>342</volume>(<issue>23</issue>):<fpage>1693</fpage>–<lpage>1700</lpage>.</citation>
</ref>
<ref id="bibr6-0003319712445374">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giles</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Rothwell</surname>
<given-names>PM</given-names>
</name>
</person-group>. <article-title>Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis</article-title>. <source>Lancet Neurol</source>. <year>2007</year>;<volume>6</volume>(<issue>12</issue>):<fpage>1063</fpage>–<lpage>1072</lpage>.</citation>
</ref>
<ref id="bibr7-0003319712445374">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paciaroni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Caso</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Venti</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Outcome in patients with stroke associated with internal carotid artery occlusion</article-title>. <source>Cerebrovasc Dis</source>. <year>2005</year>;<volume>20</volume>(<issue>2</issue>):<fpage>108</fpage>–<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr8-0003319712445374">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Weerd</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Greving</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Hedblad</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis</article-title>. <source>Stroke</source>. <year>2010</year>;<volume>41</volume>(<issue>6</issue>):<fpage>1294</fpage>–<lpage>1297</lpage>.</citation>
</ref>
<ref id="bibr9-0003319712445374">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rundek</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Arif</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Boden-Albala</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Elkind</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Paik</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Sacco</surname>
<given-names>RL</given-names>
</name>
</person-group>. <article-title>Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study</article-title>. <source>Neurology</source>. <year>2008</year>;<volume>70</volume>(<issue>14</issue>):<fpage>1200</fpage>–<lpage>1207</lpage>.</citation>
</ref>
<ref id="bibr10-0003319712445374">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klop</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Eikelboom</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Taks</surname>
<given-names>AC</given-names>
</name>
</person-group>. <article-title>Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning</article-title>. <source>Eur J Vasc Surg</source>. <year>1991</year>;<volume>5</volume>(<issue>1</issue>):<fpage>41</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr11-0003319712445374">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentile</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Moneta</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Prevalence of asymptomatic carotid stenosis in patients undergoing infrainguinal bypass surgery</article-title>. <source>Arch Surg</source>. <year>1995</year>;<volume>130</volume>(<issue>8</issue>):<fpage>900</fpage>–<lpage>904</lpage>.</citation>
</ref>
<ref id="bibr12-0003319712445374">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexandrova</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Norris</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Maggisano</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Carotid artery stenosis in peripheral vascular disease</article-title>. <source>J Vasc Surg</source>. <year>1996</year>;<volume>23</volume>(<issue>4</issue>):<fpage>645</fpage>–<lpage>649</lpage>.</citation>
</ref>
<ref id="bibr13-0003319712445374">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Harvich</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fujitani</surname>
<given-names>RM</given-names>
</name>
</person-group>. <article-title>Utility of routine carotid duplex screening in patients who have claudication</article-title>. <source>J Vasc Surg</source>. <year>1996</year>;<volume>24</volume>(<issue>4</issue>):<fpage>572</fpage>–<lpage>577</lpage>.</citation>
</ref>
<ref id="bibr14-0003319712445374">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Virgilio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Toosie</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Arnell</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Asymptomatic carotid artery stenosis screening in patients with lower extremity atherosclerosis: a prospective study</article-title>. <source>Ann Vasc Surg</source>. <year>1997</year>;<volume>11</volume>(<issue>4</issue>):<fpage>374</fpage>–<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr15-0003319712445374">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickett</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Hemann</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Atwood</surname>
<given-names>JE</given-names>
</name>
</person-group>. <article-title>Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis</article-title>. <source>Lancet</source>. <year>2008</year>;<volume>371</volume>(<issue>9624</issue>):<fpage>1587</fpage>–<lpage>1594</lpage>.</citation>
</ref>
<ref id="bibr16-0003319712445374">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liapis</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Mikhailidis</surname>
<given-names>DP</given-names>
</name>
<etal/>
</person-group>. <article-title>ESVS Guidelines: Section B—diagnosis and investigation of patients with carotid stenosis</article-title>. <source>Curr Vasc Pharmacol</source>. <year>2010</year>;<volume>8</volume>(<issue>5</issue>):<fpage>682</fpage>–<lpage>691</lpage>.</citation>
</ref>
<ref id="bibr17-0003319712445374">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Birincioglu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Arda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bardakci</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Carotid disease in patients scheduled for coronary artery bypass: analysis of 678 patients</article-title>. <source>Angiology</source>. <year>1999</year>;<volume>50</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr18-0003319712445374">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martens</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>van der</surname>
<given-names>GY</given-names>
</name>
<name>
<surname>Dijk</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Olijhoek</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Visseren</surname>
<given-names>FL</given-names>
</name>
</person-group>. <article-title>Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease</article-title>. <source>Atherosclerosis</source>. <year>2008</year>;<volume>197</volume>(<issue>2</issue>):<fpage>646</fpage>–<lpage>653</lpage>.</citation>
</ref>
<ref id="bibr19-0003319712445374">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schillinger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Exner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mlekusch</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)</article-title>. <source>Circulation</source>. <year>2005</year>;<volume>111</volume>(<issue>17</issue>):<fpage>2203</fpage>–<lpage>2209</lpage>.</citation>
</ref>
<ref id="bibr20-0003319712445374">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fabris</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zanocchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bo</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Carotid plaque, aging, and risk factors. A study of 457 subjects</article-title>. <source>Stroke</source>. <year>1994</year>;<volume>25</volume>(<issue>6</issue>):<fpage>1133</fpage>–<lpage>1140</lpage>.</citation>
</ref>
<ref id="bibr21-0003319712445374">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Mikhailidis</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Seifalian</surname>
<given-names>AM</given-names>
</name>
</person-group>. <article-title>A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors</article-title>. <source>Cardiovasc Res</source>. <year>2002</year>;<volume>54</volume>(<issue>3</issue>):<fpage>528</fpage>–<lpage>538</lpage>.</citation>
</ref>
<ref id="bibr22-0003319712445374">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutton-Tyrrell</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Alcorn</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Wolfson</surname>
<given-names>SK</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Kelsey</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Kuller</surname>
<given-names>LH</given-names>
</name>
</person-group>. <article-title>Predictors of carotid stenosis in older adults with and without isolated systolic hypertension</article-title>. <source>Stroke</source>. <year>1993</year>;<volume>24</volume>(<issue>3</issue>):<fpage>355</fpage>–<lpage>361</lpage>.</citation>
</ref>
<ref id="bibr23-0003319712445374">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerenyi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mihalka</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Csiba</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bacso</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bereczki</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Role of hyperlipidemia in atherosclerotic plaque formation in the internal carotid artery</article-title>. <source>J Clin Ultrasound</source>. <year>2006</year>;<volume>34</volume>(<issue>6</issue>):<fpage>283</fpage>–<lpage>288</lpage>.</citation>
</ref>
<ref id="bibr24-0003319712445374">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goksan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Erkol</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bozluolcay</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ince</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Diabetes as a determinant of high-grade carotid artery stenosis: evaluation of 1,058 cases by Doppler sonography</article-title>. <source>J Stroke Cerebrovasc Dis</source>. <year>2001</year>;<volume>10</volume>(<issue>6</issue>):<fpage>252</fpage>–<lpage>256</lpage>.</citation>
</ref>
<ref id="bibr25-0003319712445374">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathiesen</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Joakimsen</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bonaa</surname>
<given-names>KH</given-names>
</name>
</person-group>. <article-title>Prevalence of and risk factors associated with carotid artery stenosis: the Tromso Study</article-title>. <source>Cerebrovasc Dis</source>. <year>2001</year>;<volume>12</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr26-0003319712445374">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dharmasaroja</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Intharakham</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Risk factors for carotid stenosis in Thai patients with ischemic stroke/TIA</article-title>. <source>Angiology</source>. <year>2010</year>;<volume>61</volume>(<issue>8</issue>):<fpage>789</fpage>–<lpage>792</lpage>.</citation>
</ref>
<ref id="bibr27-0003319712445374">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stamatelopoulos</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Lekakis</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Tseke</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Differential associations of renal function with coronary and peripheral atherosclerosis</article-title>. <source>Int J Cardiol</source>. <year>2009</year>;<volume>135</volume>(<issue>2</issue>):<fpage>162</fpage>–<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr42-0003319712445374">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ciccotti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Reiche</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hagen</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Comparison of color-flow Doppler scanning, power Doppler scanning, and frequency shift for assessment of carotid artery stenosis</article-title>. <source>J Vasc Surg</source>. <year>2001</year>;<volume>34</volume>(<issue>6</issue>):<fpage>1090</fpage>–<lpage>1095</lpage>.</citation>
</ref>
<ref id="bibr28-0003319712445374">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buskens</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nederkoorn</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Buijs-Van Der Woude</surname>
<given-names> T</given-names>
</name>
<etal/>
</person-group>. <article-title>Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies</article-title>. <source>Radiology</source>. <year>2004</year>;<volume>233</volume>(<issue>1</issue>):<fpage>101</fpage>–<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr29-0003319712445374">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurvers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van der Graaf</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Blankensteijn</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Visseren</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Eikelboom</surname>
<given-names>BC</given-names>
</name>
</person-group>; <collab collab-type="author">SMART Study Group</collab>. <article-title>Screening for asymptomatic internal carotid artery stenosis and aneurysm of the abdominal aorta: comparing the yield between patients with manifest atherosclerosis and patients with risk factors for atherosclerosis only</article-title>. <source>J Vasc Surg</source>. <year>2003</year>;<volume>37</volume>(<issue>6</issue>):<fpage>1226</fpage>–<lpage>1233</lpage>.</citation>
</ref>
<ref id="bibr30-0003319712445374">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diamandopoulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goudas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Arvanitis</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Comparison of estimated creatinine clearance among five formulae (Cockroft-Gault, Jelliffe, Sanaka, simplified 4-variable MDRD and DAF) and the 24 hours-urine-collection creatinine clearance</article-title>. <source>Hippokratia</source>. <year>2010</year>;<volume>14</volume>(<issue>2</issue>):<fpage>98</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr31-0003319712445374">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timsit</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Sacco</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Mohr</surname>
<given-names>JP</given-names>
</name>
<etal/>
</person-group>. <article-title>Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism</article-title>. <source>Stroke</source>. <year>1992</year>;<volume>23</volume>(<issue>4</issue>):<fpage>486</fpage>–<lpage>491</lpage>.</citation>
</ref>
<ref id="bibr32-0003319712445374">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeng</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YC</given-names>
</name>
</person-group>. <article-title>Extracranial carotid atherosclerosis and vascular risk factors in different types of ischemic stroke in Taiwan</article-title>. <source>Stroke</source>. <year>1994</year>;<volume>25</volume>(<issue>10</issue>):<fpage>1989</fpage>–<lpage>1993</lpage>.</citation>
</ref>
<ref id="bibr33-0003319712445374">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Al-Khaffaf</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2009</year>;<volume>37</volume>(<issue>3</issue>):<fpage>262</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr34-0003319712445374">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yun</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Rho</surname>
<given-names>YN</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>UJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YW</given-names>
</name>
</person-group>. <article-title>Prevalence of asymptomatic critical carotid artery stenosis in Korean patients with chronic atherosclerotic lower extremity ischemia: is a screening carotid duplex ultrasonography worthwhile?</article-title> <source>J Korean Med Sci</source>. <year>2010</year>;<volume>25</volume>(<issue>8</issue>):<fpage>1167</fpage>–<lpage>1170</lpage>.</citation>
</ref>
<ref id="bibr35-0003319712445374">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Choe</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Ki</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Risk factor analysis for development of asymptomatic carotid stenosis in Koreans</article-title>. <source>J Korean Med Sci</source>. <year>2006</year>;<volume>21</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr36-0003319712445374">
<label>37</label>
<citation citation-type="journal">
<collab collab-type="author">European Stroke Organisation; Authors/Task Force Members</collab>, <person-group person-group-type="author">
<name>
<surname>Tendera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aboyans</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)</article-title>. <source>Eur Heart J</source>. <year>2011</year>;<volume>32</volume>(<issue>22</issue>):<fpage>2851</fpage>–<lpage>2906</lpage>. </citation>
</ref>
<ref id="bibr37-0003319712445374">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lisowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Musial</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Lisowski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Knapp</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Małyszko</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dobrzycki</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Intima-media thickness is a useful marker of the extent of coronary artery disease in patients with impaired renal function</article-title>. <source>Atherosclerosis</source>. <year>2009</year>;<volume>202</volume>(<issue>2</issue>):<fpage>470</fpage>–<lpage>475</lpage>.</citation>
</ref>
<ref id="bibr38-0003319712445374">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>An</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of rosuvastatin and atorvastatin on renal function [published online ahead of print March 1 2012]</article-title>. <source>Circ J</source>. <year>2012</year>.</citation>
</ref>
<ref id="bibr39-0003319712445374">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zureik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gariepy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Courbon</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Alcohol consumption and carotid artery structure in older French adults: the Three-City Study</article-title>. <source>Stroke</source>. <year>2004</year>;<volume>35</volume>(<issue>12</issue>):<fpage>2770</fpage>–<lpage>2775</lpage>.</citation>
</ref>
<ref id="bibr40-0003319712445374">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mowbray</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Fowkes</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Allan</surname>
<given-names>PL</given-names>
</name>
</person-group>. <article-title>Cardiovascular risk factors for early carotid atherosclerosis in the general population: the Edinburgh Artery Study</article-title>. <source>J Cardiovasc Risk</source>. <year>1997</year>;<volume>4</volume>(<issue>5-6</issue>):<fpage>357</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr41-0003319712445374">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hajat</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tilling</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Lemic-Stojcevic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>CD</given-names>
</name>
</person-group>. <article-title>Ethnic differences in risk factors for ischemic stroke: a European case-control study</article-title>. <source>Stroke</source>. <year>2004</year>;<volume>35</volume>(<issue>7</issue>):<fpage>1562</fpage>–<lpage>1567</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>